BML Capital Management »

Atea Pharmaceuticals shares owned by BML Capital Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by BML Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $22M 5.5M 4.04
2023-12-31 $17M 5.5M 3.05
2023-09-30 $14M 4.8M 3.00
2023-06-30 $8.4M 2.2M 3.74